-
Company Profile
PRA Health Sciences Inc – Company Profile
PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides outsourced clinical development and data solution services. The company offers asset valuation, regulatory and drug development consulting, risk-based monitoring, site identification and selection, medical writing, validation, commercialization, data management, statistical analysis, clinical pharmacology and other services. It provides services in the therapeutic areas of oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic and infectious diseases. PRA serves pharmaceutical and biotechnology industries. The company has operations across North...
Add to Basket -
Company Profile
I-Mab – Company Profile
I-Mab(I-Mab) is a biopharmaceutical company. It develops transformational medicines for therapeutic areas of immuno-oncology and autoimmune diseases. Its pipeline product portfolio comprises TJ202, a CD38 antibody for treating multiple myeloma; TJ101, a recombinant human growth hormone (rhGH) used in pediatric patients with growth hormone deficiency; TJ301, an IL-6 inhibitor for ulcerative colitis; enoblituzumab, a B7-H3 antibody against tumors; and TJ107, an oncology care agent to treat cancer treatment-related lymphopenia. I-Mab utilizes various molecular engineering platforms to develop drug molecules with...
Add to Basket -
Company Profile
Hangzhou Tigermed Consulting Co Ltd – Company Profile
Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a clinical research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical device testing, patient recruitment, clinical evaluation and development, data management, biostatistics and statistical programming services. The company also provides integrated technology services including site management, pharmacovigilance, third-party audit and training, medical imaging and clinical trial system solutions. Tigermed conducts research in the therapeutic areas...
Add to Basket -
Product Insights
One Way Liver SL Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our One Way Liver SL Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. One Way Liver SL (OWL) develops, discovers, and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver that is a serum based test used for steatosis and NASH diagnosis. It also provides services such as biomarker search and identification, companion diagnostics, screening services, and drug development optimization. OWL offers metabolomic services to pharmaceutical...
-
Sector Analysis
Healthcare Expenditure and Pharmaceutical Sales by Region, Patent Expiries and New Technologies – Overview of 2022 and Outlook for 2023
Accessing the in-depth insight from the ‘Healthcare and Pharmaceutical Market’ report can help you: Identify the broader macroeconomic environment and industry-specific trends that will impact the outlook of the global pharmaceutical sector. Analyze how technology developments, patent expirations, M&A, and healthcare policy reforms are impacting the outlook of the pharmaceutical industry. Identify key drivers across patent expirations, new technologies and M&A. How is the 'Healthcare and Pharmaceutical Market' report different from other reports in the market? The report offers a global...
-
Sector Analysis
Pharma Pricing and Reimbursement and Market Access Risk Scores (MARS) by Region – Overview of 2022 and Outlook for 2023
Accessing the in-depth insight from the ‘Pharma Pricing and Reimbursement’ report can help you - Understand the latest/global outlook for pricing and market access reforms in the pharmaceutical industry such as HTA reforms. Understand price cuts/increases and reimbursement restrictions around the world through unique price intelligence and data. Identify the potential regions (Europe, Latin America, APAC and North America) and target the markets best suited to strategic focus. Benchmark launch sequence and P&R strategies with the risk scores for each potential...
-
Report Bundle
58% offTech in Pharma – Report Bundle (7 Reports)
Tech in Pharma Bundle Report Overview Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience. Explore actionable market...
-
Report Bundle
56% offTrends in Medical Devices – Report Bundle (7 Reports)
A rise in disease awareness, improved accessibility to personalized medicine, and technological advancements are transforming the medical device industry. It is helping patients to avoid potential adverse events and reducing unnecessary hospitalizations and outpatient costs. The field has expanded from a handful of drug manufacturers to include many high-end manufacturers. Accessing the in-depth insight from the Trends in Medical Devices bundle can help you: Make informed decisions about investments, partnerships, and product development Understand your competitors’ strengths and weaknesses, identify areas...
-
Product Insights
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peripheral vascular disease (PVD) refers to diseases of the blood vessels (arteries and veins) located outside the heart and brain. Symptoms include painful cramping in hip, thigh, or calf muscles after activity, such as walking or climbing stairs (intermittent claudication), leg numbness or weakness, coldness in the lower leg or foot, especially when compared with the other side, sores on toes, feet or legs that won't heal, slower growth of toenails and erectile dysfunction in men. The PVD pipeline drugs...
-
Product Insights
Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Acromegaly clinical trial market research report provides an overview of the Acromegaly clinical trials scenario. The report provides top-line data relating to the clinical trials on Acromegaly. The Acromegaly, 2022 report includes an overview of trial numbers and their average enrollment in top countries conducted globally. The clinical trials report also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.